在临床前实验中减少样本大小:贝叶斯的顺序决策框架
Jizhou Kang1, Theodoro Koulis2, Tony Pourmohamad2
1Department of Statistics, University of California, Santa Cruz, USA.
Journal of biopharmaceutical statistics
|September 11, 2025
概括
这项研究引入了临床前实验的顺序框架,以减少动物使用. 通过在每个阶段评估结果的有效性或徒劳性,这种方法旨在比传统方法更有效地将动物数量最小化.
科学领域:
- 临床前研究方法学
- 研究中的动物福利.
- 生物统计学和实验设计.
背景情况:
- 关于动物福利的伦理问题在临床前研究中至关重要.
- 3Rs原则 (取代,减少,改进) 指导人性化动物研究.
- 目前的方法往往缺乏有效的策略来减少动物数量.
研究的目的:
- 为临床前实验提出和评估一个新的序列框架.
- 通过提前停止有效性或徒劳性来增强3Rs的减少方面.
- 尽量减少临床前研究所需的动物数量.
主要方法:
- 提出了一种连续的实验设计,允许进行中间分析.
- 在每个阶段的决策过程中,都需要检查实验结果.
- 损失函数是指定的,以指导基于后期预期损失的早期停止决策.
主要成果:
- 与传统方法相比,拟议的框架显示了进一步减少动物数量的潜力.
- 涉及双臂实验的模拟与二进制和连续端点支持该方法.
- 该设计适用于现实世界临床前实验场景.
结论:
- 顺序框架提供了一个统计学上合理的方法来减少在临床前研究中的动物使用.
- 实施早期停止有效性或徒劳性优化资源分配和动物福利.
- 这种方法为更人道,更有效的临床前研究设计提供了宝贵的工具.
相关概念视频
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
409
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
409
Decision Making: P-value Method
6.8K
The process of hypothesis testing based on the P-value method includes calculating the P- value using the sample data and interpreting it.
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can...
First, a specific claim about the population parameter is proposed. The claim is based on the research question and is stated in a simple form. Further, an opposing statement to the claim is also stated. These statements can act as null and alternative hypotheses: a null hypothesis would be a neutral statement while the alternative hypothesis can...
6.8K
Sample Size Calculation
6.4K
Knowledge of the sample size is the first requirement to conduct random sampling or an experiment. The sample size is the total number of units, observations, or groups (in some cases) used to get the data to estimate a population parameter. As the name suggests, the sample size is that of the sample drawn from the population and differs from the population size.
The sample size for the given experiment or sampling effort is fundamental to any study design. Sample size decides the number of...
The sample size for the given experiment or sampling effort is fundamental to any study design. Sample size decides the number of...
6.4K
Preclinical Development: Overview
5.9K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.9K
Randomized Experiments
8.9K
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
8.9K


